Evidence mapPaperPMID 40900772Full record

ReviewWorld journal of gastroenterology2025

Interplay between endocrine disorders and liver dysfunction: Mechanisms of damage and therapeutic approaches.

Andres M Vargas-Beltran, Samantha M Armendariz-Pineda, Froylan D Martínez-Sánchez, Carolina Martinez-Perez, Aldo Torre, Jacqueline Cordova-Gallardo

Abstract readReview
In one paragraph

Review in World journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Protective effects ofRedox report : communications in free radical research · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Andres M Vargas-BeltranDepartment of Hepatology, General Hospital Dr. Manuel Gea Gonzalez, Mexico City 14080, Mexico.
Samantha M Armendariz-PinedaDepartment of Hepatology, General Hospital Dr. Manuel Gea Gonzalez, Mexico City 14080, Mexico.
Froylan D Martínez-SánchezFaculty of Medicine, National University Autonomous of Mexico, Mexico City 04360, Mexico.
Carolina Martinez-PerezDepartment of Hepatology, General Hospital Dr. Manuel Gea Gonzalez, Mexico City 14080, Mexico.
Aldo TorreDepartment of Gastroenterology, Centro Médico ABC, Mexico City 05300, Mexico.
Jacqueline Cordova-GallardoDepartment of Hepatology, General Hospital Dr. Manuel Gea Gonzalez, Mexico City 14080, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endocrine disorders frequently lead to metabolic disturbances that significantly affect liver function. Understanding the complex interplay between hormonal imbalances and liver dysfunction is essential for advancing targeted therapeutic strategies. This comprehensive review explores the pathophysiological mechanisms linking major endocrine disorders to liver disease, with a focus on the roles of the thyroid, parathyroid, pancreas, adrenal glands, and sex hormones. Thyroid dysfunction is associated with alterations in liver enzyme levels and metabolic regulation, often resulting in hepatic steatosis or cholestasis. Hyperparathyroidism and consequent hypercalcemia have been linked to hepatic calcifications. Insulin resistance, both hepatic and peripheral, contributes to excessive lipid accumulation in the liver, exacerbating steatotic changes. Adrenal gland disorders, particularly in the setting of chronic liver disease, impair cortisol metabolism and may worsen hepatic injury. Additionally, sex hormones such as estrogen and testosterone modulate the progression of liver fibrosis and influence the development of metabolic syndrome. The intricate relationship between endocrine and hepatic systems underscores the need for a multidisciplinary approach in the management of liver disease. Addressing underlying hormonal disturbances may enhance patient outcomes and prevent further hepatic deterioration. Future research should prioritize integrative therapeutic strategies that concurrently target endocrine and liver dysfunction.

Indexed as

Endocrine System DiseasesLiverLiver DiseasesGonadal Steroid HormonesHumansInsulin ResistanceGonadal Steroid HormonesCirrhosisEndocrine disordersHormonal imbalanceLiver diseaseLiver dysfunctionLiver pathologyMetabolic liver disease

Identifiers

PMID40900772
PMCPMC12400232

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.